Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.01 and traded as low as $0.0076. Evofem Biosciences shares last traded at $0.0083, with a volume of 67,052 shares traded.
Evofem Biosciences Stock Performance
The business has a 50-day moving average price of $0.01 and a two-hundred day moving average price of $0.01. The firm has a market capitalization of $1.06 million, a price-to-earnings ratio of -0.01 and a beta of -1.32.
About Evofem Biosciences
Evofem Biosciences is a clinical‐stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.
The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.
Read More
- Five stocks we like better than Evofem Biosciences
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
